334 related articles for article (PubMed ID: 30326332)
21. Tolerability and efficacy of oral loading of levetiracetam.
Koubeissi MZ; Amina S; Pita I; Bergey GK; Werz MA
Neurology; 2008 May; 70(22 Pt 2):2166-70. PubMed ID: 18505995
[TBL] [Abstract][Full Text] [Related]
22. Levetiracetam in children with refractory epilepsy: lack of correlation between plasma concentration and efficacy.
Giroux PC; Salas-Prato M; Théorêt Y; Carmant L
Seizure; 2009 Oct; 18(8):559-63. PubMed ID: 19546014
[TBL] [Abstract][Full Text] [Related]
23. Lipid and thyroid hormone levels in children with epilepsy treated with levetiracetam or carbamazepine: A prospective observational study.
Nishiyama M; Takami Y; Ishida Y; Tomioka K; Tanaka T; Nagase H; Nakagawa T; Tokumoto S; Yamaguchi H; Toyoshima D; Maruyama A; Nozu K; Nishimura N; Iijima K
Epilepsy Behav; 2019 Jan; 90():15-19. PubMed ID: 30500483
[TBL] [Abstract][Full Text] [Related]
24. Assessment of psychiatric and behavioral adverse effects of antiepileptic drugs monotherapy: Could they have a neuroendocrine correlation in persons with epilepsy?
Sarangi SC; Kaur N; Tripathi M
Epilepsy Behav; 2019 Nov; 100(Pt A):106439. PubMed ID: 31574428
[TBL] [Abstract][Full Text] [Related]
25. Metabolic syndrome and obstructive sleep apnea syndrome among patients with epilepsy on monotherapy.
Söylemez E; Öztürk O; Baslo SA; Balçık ZE; Ataklı D
Epilepsy Behav; 2020 Oct; 111():107296. PubMed ID: 32769040
[TBL] [Abstract][Full Text] [Related]
26. Association of Levetiracetam Concentration With Seizure Frequency in Pregnant Women With Epilepsy.
Schelhaas M; Wegner I; Edens M; Wammes-Van Der Heijden E; Touw D; Ter Horst P
Neurology; 2023 Jan; 100(2):e172-e181. PubMed ID: 36257713
[TBL] [Abstract][Full Text] [Related]
27. Levetiracetam in toxic seizures.
Lee T; Warrick BJ; Sarangarm P; Alunday RL; Bussmann S; Smolinske SC; Seifert SA
Clin Toxicol (Phila); 2018 Mar; 56(3):175-181. PubMed ID: 28753046
[TBL] [Abstract][Full Text] [Related]
28. Pharmacodynamic and pharmacokinetic characterization of interactions between levetiracetam and numerous antiepileptic drugs in the mouse maximal electroshock seizure model: an isobolographic analysis.
Luszczki JJ; Andres MM; Czuczwar P; Cioczek-Czuczwar A; Ratnaraj N; Patsalos PN; Czuczwar SJ
Epilepsia; 2006 Jan; 47(1):10-20. PubMed ID: 16417526
[TBL] [Abstract][Full Text] [Related]
29. Quality of life after switching to generic levetiracetam - A prospective comparative study.
Olsson P; Reimers A; Källén K
Epilepsy Behav; 2019 Jul; 96():169-174. PubMed ID: 31150996
[TBL] [Abstract][Full Text] [Related]
30. Serum concentrations of Levetiracetam in epileptic patients: the influence of dose and co-medication.
May TW; Rambeck B; Jürgens U
Ther Drug Monit; 2003 Dec; 25(6):690-9. PubMed ID: 14639055
[TBL] [Abstract][Full Text] [Related]
31. [Paradoxical effect of levetiracetam on seizure suppression: three cases showing U curve association between dose and effect].
Inoue T; Kobayashi K; Usami K; Shimotake A; Inouchi M; Sakai T; Ikeda A; Takahashi R
Rinsho Shinkeigaku; 2021 Apr; 61(4):247-252. PubMed ID: 33762498
[TBL] [Abstract][Full Text] [Related]
32. Synaptic vesicle protein 2A tumoral expression predicts levetiracetam adverse events.
Romoli M; Mandarano M; Romozzi M; Eusebi P; Bedetti C; Nardi Cesarini E; Verzina A; Calvello C; Loreti E; Sidoni A; Giovenali P; Calabresi P; Costa C
J Neurol; 2019 Sep; 266(9):2273-2276. PubMed ID: 31168673
[TBL] [Abstract][Full Text] [Related]
33. Comparative effectiveness of levetiracetam, valproate and carbamazepine among elderly patients with newly diagnosed epilepsy: subgroup analysis of the randomized, unblinded KOMET study.
Pohlmann-Eden B; Marson AG; Noack-Rink M; Ramirez F; Tofighy A; Werhahn KJ; Wild I; Trinka E
BMC Neurol; 2016 Aug; 16(1):149. PubMed ID: 27552848
[TBL] [Abstract][Full Text] [Related]
34. Carbamazepine versus levetiracetam in epilepsy due to neurocysticercosis.
Santhosh AP; Kumar Goyal M; Modi M; Kharbanda PS; Ahuja CK; Tandyala N; Prabhat N; Singh R; Mehta S; Vinay Mahesh K
Acta Neurol Scand; 2021 Mar; 143(3):242-247. PubMed ID: 33006755
[TBL] [Abstract][Full Text] [Related]
35. Effect of chronic administration of phenobarbital, or bromide, on pharmacokinetics of levetiracetam in dogs with epilepsy.
Muñana KR; Nettifee-Osborne JA; Papich MG
J Vet Intern Med; 2015; 29(2):614-9. PubMed ID: 25711374
[TBL] [Abstract][Full Text] [Related]
36. Serum concentration/dose ratio of levetiracetam before, during and after pregnancy.
Westin AA; Reimers A; Helde G; Nakken KO; Brodtkorb E
Seizure; 2008 Mar; 17(2):192-8. PubMed ID: 18180176
[TBL] [Abstract][Full Text] [Related]
37. Levetiracetam monotherapy in children with epilepsy: Experience from a tertiary pediatric neurology center.
Yıldırım M; Bektaş Ö; Akıncı Göktaş Ö; Yüksel MF; Şahin S; Tıraş Teber S
Epilepsy Behav; 2021 Mar; 116():107745. PubMed ID: 33508749
[TBL] [Abstract][Full Text] [Related]
38. An interaction study of Ocimum sanctum L. and levetiracetam in pentylenetetrazole kindling model of epilepsy.
Sarangi SC; Pattnaik SS; Katyal J; Kaleekal T; Dinda AK
J Ethnopharmacol; 2020 Mar; 249():112389. PubMed ID: 31739106
[TBL] [Abstract][Full Text] [Related]
39. [Efficacy and safety of levetiracetam (keppra) add-on treatment in adult patients with refractory epilepsy in two tertiary centers].
Auriel E; Chistik V; Blatt I; Margolin N; Neufeld M
Harefuah; 2007 Apr; 146(4):269-71, 318. PubMed ID: 17476932
[TBL] [Abstract][Full Text] [Related]
40. Usefulness of perampanel with concomitant levetiracetam for patients with drug-resistant epilepsy.
Kanemura H; Sano F; Aihara M
Eur J Paediatr Neurol; 2019 Jan; 23(1):197-203. PubMed ID: 30424990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
